Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

47.83 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
40 41 Next >
News headline image
Clovis Oncology (CLVS) Stock Rallies on Buyout Rumors ↗
Pharmaceutical startup CLVS stock is climbing 25% higher today on rumors that the cancer drug maker has become a takeover target. 
Via InvestorPlace
News headline image
Morning Brief: Top Financial Stories Dominating on Monday, June 13 ↗
CNBC JPMorgan Remains Bullish On Alibaba And Other Chinese Stocks - Here’s Why 
Via Benzinga
News headline image
Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern ↗
 
Via Benzinga
News headline image
We're Looking At Obesity In A New Way — And 4 Pharmaceutical Stocks Could Benefit ↗
The conversation around obesity is changing. Two diabetes drug makers are at the forefront. 
Via Investor's Business Daily
Pfizer’s CDI Trial Miss Puts Acurx Pharmaceuticals Ibezapolstat In Front-Line Position, Here’s Why Big Pharma May Come Calling ($ACXP)
Via AB Newswire
News headline image
FDA Accepts Regeneron, Sanofi's Filing For Review In Skin Disease ↗
The U.S. 
Via Benzinga
News headline image
Why Kymera Therapeutics Shares Are Falling Today ↗
 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
U.S. FDA Approves Regeneron And Sanofi's Lead Drug For Skin Inflammation In Children ↗
The U.S. 
Via Benzinga
News headline image
CStone Pharma Replaces Chairman Amid Huge Losses, Irregular Investment ↗
Key Takeaways: CStone brought four products to market last year, and its losses have surged due to growing R&D and sales spending Appointment of chairman with close ties... 
Via Benzinga
Acurx Pharmaceuticals Is Under The Radar, That’s Excellent News For Investors Wanting Exposure To Billion Dollar CDI Treatment Market ($ACXP)
Via AB Newswire
News headline image
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More ↗
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended. 
Via Benzinga
News headline image
Regeneron Pharmaceuticals Dives On $1.1 Billion Deal To Rival Merck In Cancer ↗
Regeneron secured the global rights to Sanofi-partnered Libtayo. 
Via Investor's Business Daily
News headline image
3 Biotech Stocks to Buy Before They Boom ↗
It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations. 
Via InvestorPlace
News headline image
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates ↗
May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,... 
Via Benzinga
Revolutionary Heart Therapy Offers Hope to Patients and Investors Alike
Palm Beach, FL – May 31, 2022 – FinancialNewsMedia.com News Commentary – Diabetes is a chronic health condition that occurs when your body’s blood glucose, also called blood sugar, is too high. Blood... 
Via FinancialNewsMedia
News headline image
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More ↗
Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support. 
Via Benzinga
News headline image
FDA Approves Regeneron and Sanofi's Dupixent (dupilumab) For Eosinophilic Esophagitis (EoE) Ahead of Schedule ↗
The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals, Inc. 
Via Benzinga
News headline image
The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
7 Penny Stocks With 10x Potential This Year ↗
These penny stocks all have 10x potential or greater during the remainder of 2022. They are risky but relatively straightforward. 
Via InvestorPlace
News headline image
Sanofi To Pay €400K As Compensation For Epilepsy Drug-Related Side Effects ↗
A French court has ordered Sanofi SA (NASDAQ: SNY) to pay more than €400,000 in damages to a French family whose child had autism caused by its epilepsy drug Valproate. 
Via Benzinga
News headline image
Sanofi Says Sarclisa Shows 'Unprecedented Median Progression-Free Survival' In Multiple Myeloma Patients ↗
 
Via Benzinga
News headline image
Eli Lilly, Novo Nordisk, Sanofi Accused Of Artificially Raising Insulin Prices ↗
Arkansas has accused Eli Lilly And Co (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Sanofi SA (NASDAQ: SNY), and three of the largest pharmacy benefit... 
Via Benzinga
News headline image
Why Tech Leader Regeneron Shouldn't Sweat Its AbbVie Rival — For Now ↗
The race is on in eczema treatment as the biggest name faces new rivals. 
Via Investor's Business Daily
News headline image
Psychedelic Medicine: The New Frontier In Healthcare, The Big Opportunity In Biopharma ↗
The story around psychedelic medicine continues to get bigger. 
Via Talk Markets
News headline image
Is Dario (DRIO) Health Eating Teladoc's (TDOC) Lunch? Q1 Earnings on Tap Thursday After Meeting with Sanofi (SNY) ↗
Teladoc (NYSE: TDOC) stock recently cratered to a new 52 week low following it’s Q1 report. Some of it’s shortfall was attributed by management to longer sales cycles in the insurer and employer space... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV ↗
Sanofi SA (NASDAQ: SNY) and AstraZeneca plc (NASDAQ: AZN) have announced results from a prespecified pooled analysis of nirsevimab in respiratory syncytial virus (RSV). 
Via Benzinga
Heart Failure Treatment Offers Hope to Diabetics
Palm Beach, FL – May 11, 2022 – FinancialNewsMedia.com News Commentary – Diabetes and heart failure are closely linked. People with type 2 diabetes are two to four times more likely to develop heart... 
Via FinancialNewsMedia
News headline image
7 Biotech Stocks With Key Catalysts for May ↗
The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns. 
Via InvestorPlace
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
40 41 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.